Protection of chickens against avian influenza with nonreplicating adenovirus-vectored vaccine

Poultry Science

Volumn 88, Issue 4, 2009, Pages 867-871

  Toro, H ^a   Tang, D C ^b  

^a AUBURN UNIVERSITY   (United States)

^b Vaxin Incorporated   (United States)

Author keywords

Avian influenza; Recombinant adenovirus; Vaccine

Indexed keywords

ADENOVIRIDAE; AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; ORTHOMYXOVIRIDAE; SPONDIAS PURPUREA;

DNA VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ADENOVIRUS; ANIMAL; ARTICLE; AVIAN INFLUENZA; CHICKEN; CLASSIFICATION; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CHICKENS; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; VACCINES, DNA; VIRUS REPLICATION;

EID: 65549163875     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2008-00333     Document Type: Article

References (26)

1. Capua, I., S. Marangon, M. Dalla Pozza, and U. Santucci. 2000. Vaccination for avian influenza in Italy. Vet. Rec. 147:751.
2. Gao, W., A. C. Soloff, X. Lu, A. Montecalvo, D. C. Nguyen, Y. Matsuoka, P. D. Robbins, D. E. Swayne, R. O. Donis, J. M. Katz, S. M. Barratt-Boyes, and A. Gambotto. 2006. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 80:1959-1964.
3. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
4. Hilleman, M. R. 2002. Realities and enigmas of human viral influenza: Pathogenesis, epidemiology and control. Vaccine 20:3068-3087.
5. Konz, J. O., R. C. Livingood, A. J. Bett, A. R. Goerke, M. E. Laska, and S. L. Sagar. 2005. Serotype specificity of adenovirus purification using anion-exchange chromatography. Hum. Gene Ther. 16:1346-1353.
6. Lee, C. W., D. A. Senne, and D. L. Suarez. 2004. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza. Vaccine 22:3175-3181.
7. Lewis, J. A., E. L. Brown, and P. A. Duncan. 2006. Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines. Dev. Biol. (Basel) 123:165-176.
8. Mossadegh, N., L. Gissmann, M. Muller, H. Zentgraf, A. Alonso, and P. Tomakidi. 2004. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 326:57-66.
9. Park, M. S., J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese. 2006. Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. USA 103:8203-8208.
10. Ramakrishna, L., K. K. Anand, K. M. Mohankumar, and U. Ranga. 2004. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization. J. Virol. 78:9174-9189.
11. Sharma, J. M., and B. R. Burmester. 1982. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis. 26:134-149.
12. Shi, Z., M. Zeng, G. Yang, F. Siegel, L. J. Cain, K. R. Van Kampen, C. A. Elmets, and D. C. Tang. 2001. Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines. J. Virol. 75:11474-11482.
13. Suarez, D. L., and S. Schultz-Cherry. 2000. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Dis. 44:861-868.
14. Suarez, D. L., D. A. Senne, J. Banks, I. H. Brown, S. C. Essen, C.- W. Lee, R. J. Manwell, C. Mathieu-Benson, V. Moreno, J. C. Pedersen, B. Panigraphy, H. Rojas, E. Spackman, and D. J. Alexander. 2004. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg. Infect. Dis. 10:693-699.
15. Swayne, D. E. 2003. Vaccines for List A poultry diseases: Emphasis on avian influenza. Dev. Biol. (Basel) 114:201-212.
16. Swayne, D. E., J. R. Beck and N. Kinney. 2000a. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis. 44:132-137.
17. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez. 2000b. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowl- pox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18:1088-1095.
18. Swayne, D. E., M. L. Perdue, J. R. Beck, M. Garcia, and D. L. Suarez. 2000c. Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years. Vet. Microbiol. 74:165-172.
19. Swayne, D. E., D. A. Senne, and C. W. Beard. (1998). Influenza. 4th ed. Pages 150-155 in "Isolation and Identification of Avian Pathogens." D. E. Swayne, J. R. Glisson, M. W. Jackwood, J. E. Pearson, and W. M. Reed, ed. Am. Assoc. Avian Pathol., Ken- nett Square.
20. Toro, H., D. C. Tang, D. L. Suarez, M. J. Sylte, J. Pfeiffer, and K. R. Van Kampen. 2007. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine 25:2886-2891.
21. Toro, H., D. C. Tang, D. L. Suarez, J. Zhang, and Z. Shi. 2008. Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine. Vaccine 26:2640-2646.
22. Ungchusak, K., P. Auewarakul, S. F. Dowell, R. Kitphati, W. Auwanit, P. Puthavathana, M. Uiprasertkul, K. Boonnak, C. Pittayawonganon, N. J. Cox, S. R. Zaki, P. Thawatsupha, M. Chittaganpitch, R. Khontong, J. M. Simmerman, and S. Chunsutthiwat. 2005. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 352:333-340.
23. Van Kampen, K. R., Z. Shi, P. Gao, J. Zhang, K. W. Foster, D. T. Chen, D. Marks, C. A. Elmets, and D. C. Tang. 2005. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 23:1029-1036.
24. Wakenell, P. S., T. Bryan, J. Schaeffer, A. Avakian, C. Williams, and C. Whitfill. 2002. Effect of in ovo vaccine delivery route on herpesvirus of turkeys/SB-1 efficacy and viremia. Avian Dis. 46:274-280.
25. World Organization for Animal Health (OIE), Food and Agriculture Organization of the United Nations (FAO). 2005. Recommendations of the OIE/FAO International Scientific Conference on Avian Influenza. Paris, 7 - 8 April 2005.www.oie.int/eng/avian-influenza/OIE_FAO_Recom_05.pdf Accessed Oct. 8, 2008
26. Zhu, J., M. Grace, J. Casale, A. T. Chang, M. L. Musco, R. Bordens, R. Greenberg, E. Schaefer, and S. R. Indelicato. 1999. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum. Gene Ther. 10:113-121.